Search

Your search keyword '"Ordi-Ros, J"' showing total 282 results

Search Constraints

Start Over You searched for: Author "Ordi-Ros, J" Remove constraint Author: "Ordi-Ros, J"
282 results on '"Ordi-Ros, J"'

Search Results

4. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

5. Opposed independent effects and epistasis in the complex association of IRF5 to SLE

9. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

18. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

19. Anti-PDGFR-[alpha] antibodies measured by non-bioactivity assays are not specific for systemic sclerosis

22. AB0451 Rivaroxaban versus warfarin as secondary thromboprophylaxis in patients with antiphospholipid syndrome protocol: a randomized, multicentre, open-label, clinical trial

23. Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis.

24. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

27. Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study

28. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis

32. Prevalence of HHV-8 in systemic autoimmune diseases

33. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial

34. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

35. Opposed independent effects and epistasis in the complex association of IRF5 to SLE

36. DUSP23 is over-expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients.

42. THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

43. Sequence analysis of TMEM173 exon 5 in patients with systemic autoimmune diseases.

Catalog

Books, media, physical & digital resources